COBRE Pilot: Evaluation of Highly Selective mPGES-1 Inhibotor, UK4b, as a Non-addictive Orofacial Pain Medication

Pharmacology, Toxicology and Pharmaceutical Science

1. Pain 100%
2. Celecoxib 50%
3. Non-Steroidal Anti-Inflammatory Drug 50%
4. Analgesic Agent 50%
5. Opiate 50%
6. Toxic Injury 25%
7. Anti-Inflammatory Drug 25%
8. Side Effect 25%
9. Chronic Pain 25%
10. Lead Compound 25%
11. Neuropathic Pain 25%
12. Lead 25%
13. Addiction 25%
14. Inflammatory Pain 25%
15. Inflammation 25%